Persistence Market Research Company
Customize Now Report Sample

Ischemic Optic Neuropathy Treatment Market Size, Share, Growth, and Regional Forecast, 2025 to 2032

Ischemic Optic Neuropathy Treatment Market by Drug Class (Corticosteroids, Antimetabolites, Anticoagulants, Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs), Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Route of Administration, Indication, Distribution Channel, and Regional Analysis from 2025 to 2032

ID: PMRREP23077| 192 Pages | 30 Sep 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Ischemic Optic Neuropathy Treatment Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Product Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Ischemic Optic Neuropathy Treatment Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
    3. Global Ischemic Optic Neuropathy Treatment Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
        1. Corticosteroids
        2. Antimetabolites
        3. Anticoagulants
        4. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
        5. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
      4. Market Attractiveness Analysis: Drug Class
    4. Global Ischemic Optic Neuropathy Treatment Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
        1. Oral
        2. Injectable
      4. Market Attractiveness Analysis: Route of Administration
    5. Global Ischemic Optic Neuropathy Treatment Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
        1. Posterior Ischemic Optic Neuropathy
        2. Anterior Ischemic Optic Neuropathy
          1. Arteritic AION (A-AION)
          2. Non-Arteritic AION (NA-AION)
      4. Market Attractiveness Analysis: Indication
    6. Global Ischemic Optic Neuropathy Treatment Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019-2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025-2032
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
  5. Global Ischemic Optic Neuropathy Treatment Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
    3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Ischemic Optic Neuropathy Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By Indication
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. U.S.
      2. Canada
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Corticosteroids
      2. Antimetabolites
      3. Anticoagulants
      4. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
      5. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Posterior Ischemic Optic Neuropathy
      2. Anterior Ischemic Optic Neuropathy
        1. Arteritic AION (A-AION)
        2. Non-Arteritic AION (NA-AION)
    7. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  7. Europe Ischemic Optic Neuropathy Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By Indication
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Corticosteroids
      2. Antimetabolites
      3. Anticoagulants
      4. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
      5. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Posterior Ischemic Optic Neuropathy
      2. Anterior Ischemic Optic Neuropathy
        1. Arteritic AION (A-AION)
        2. Non-Arteritic AION (NA-AION)
    7. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  8. East Asia Ischemic Optic Neuropathy Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By Indication
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Corticosteroids
      2. Antimetabolites
      3. Anticoagulants
      4. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
      5. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Posterior Ischemic Optic Neuropathy
      2. Anterior Ischemic Optic Neuropathy
        1. Arteritic AION (A-AION)
        2. Non-Arteritic AION (NA-AION)
    7. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  9. South Asia & Oceania Ischemic Optic Neuropathy Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By Indication
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Corticosteroids
      2. Antimetabolites
      3. Anticoagulants
      4. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
      5. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Posterior Ischemic Optic Neuropathy
      2. Anterior Ischemic Optic Neuropathy
        1. Arteritic AION (A-AION)
        2. Non-Arteritic AION (NA-AION)
    7. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  10. Latin America Ischemic Optic Neuropathy Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By Indication
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Corticosteroids
      2. Antimetabolites
      3. Anticoagulants
      4. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
      5. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Posterior Ischemic Optic Neuropathy
      2. Anterior Ischemic Optic Neuropathy
        1. Arteritic AION (A-AION)
        2. Non-Arteritic AION (NA-AION)
    7. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  11. Middle East & Africa Ischemic Optic Neuropathy Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Drug Class
      3. By Route of Administration
      4. By Indication
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025-2032
      1. Corticosteroids
      2. Antimetabolites
      3. Anticoagulants
      4. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
      5. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    5. Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Injectable
    6. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Posterior Ischemic Optic Neuropathy
      2. Anterior Ischemic Optic Neuropathy
        1. Arteritic AION (A-AION)
        2. Non-Arteritic AION (NA-AION)
    7. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. AbbVie Inc.
        1. Overview
        2. Segments and Product Types
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Eli Lily Company
      3. GlaxoSmithKline
      4. Pfizer Inc.
      5. Teva Pharmaceuticals USA, Inc.
      6. Bausch Health Companies Inc.
      7. F. Hoffmann-La Roche AG
      8. Bayer AG
      9. Sanofi A.S.
      10. Bristol-Myers Squibb and Company
      11. AdvaCare Pharma
      12. ANI Pharmaceuticals, Inc.
      13. Jubilant Cadista Pharmaceuticals Inc.
      14. Strides Pharma Science Limited
      15. Boehringer Ingelheim International GmbH
      16. Amgen Inc.
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate